Professor Davis is a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He is also the author of more than 375 scientific publications, two textbooks and over 50 patents and presents as a distinguished lecturer in the third annual Henry A. McGee, Jr. Ph.D. Chemical and Life Science Engineering lecture series. Professor Davis will present the current understandings of why engineered, nanosized medicines that are highly multifunctional chemical systems have the potential to provide game changing ways to treat cancer. The nanoscale matters. He will illustrate this point by demonstrating how physical insights at the nanoscale allow for the development of nanoparticles that can function as intended in animals and humans. The data from humans will be used to show how he and his research team have translated two independent nanoparticle cancer therapeutics from laboratory curiosities to experimental therapeutics in human clinical trials.
Engineering:Chemical & Life Science Engineering
Mark E. Davis, Ph.D. Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology
VCU Alumni, VCU Faculty, VCU Health Care Providers, VCU Physicians, VCU Staff, VCU Students , Administration , Community Based Physicians, New Students, School of Medicine